Significance of RNA reference in tumour-related gene expression analyses by cDNA array

Anticancer Research

Volumn 25, Issue 2 B, 2005, Pages 1397-1407

  Laytragoon Lewin, Nongnit ^a   Lagerlund, Magnus ^a   Lundgren, Jan ^a   Nordlander, Britt ^a   Elmberger, Göran ^a   Södergren, Towe ^a   Lagerros, Christofer ^a   Rutqvist, Lars Erik ^a   Lewin, Freddi ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cDNA array; Reference RNA

Indexed keywords

COMPLEMENTARY DNA; REFERENCE RNA; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TUMOR BIOPSY;

ADULT; AGED; BIOPSY; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; TUMOR CELLS, CULTURED;

EID: 17444381611     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Miller LD, Long PM, Wong L, Mukherjee S, McShane LM and Liu ET: Optimal gene expression analysis by microarrays. Cancer Cell 2(5): 353-61, 2002.
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769): 503-11, 2000.
3. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al: Molecular portraits of human breast tumours. Nature 406(6797): 747-52, 2000.
4. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871): 530-6, 2002.
5. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A et al: Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61(16): 5979-84, 2001.
6. Boussioutas A, Li H, Liu J, Waring P, Lade S, Holloway AJ et al: Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res 63(10): 2569-77, 2003.
7. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346(25): 1937-47, 2002.
8. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R et al: Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98(20): 11462-7, 2001.
9. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98(24): 13790-5, 2001.
10. Braakhuis BJ: Using tissue adjacent to carcinoma as a normal control. J Pathol 203: 620-621, 2004
11. Klein E, Ben-Bassat H, Neumann H, Ralph P, Zeuthen J, Polliack A et al: Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer 18(4): 421-31, 1976.
12. Rheinwald JG and Beckett MA: Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 41(5): 1657-63, 1981.
13. Lewin N, Aman P, Mellstedt H, Zech L and Klein G: Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines. Int J Cancer 41(6): 892-5, 1988.
14. Rhim JS, Jay G, Arnstein P, Price FM, Sanford KK and Aaronson SA: Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science 227(4691): 1250-2, 1985.
15. Rangan SR: A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer 29(1): 117-21, 1972.
16. Peterson WD Jr, Stulberg CS and Simpson WF: A permanent heteroploid human cell line with type B glucose-6-phosphate dehydrogenase. Proc Soc Exp Biol Med 136(4): 1187-91, 1971.
17. Lipford E, Wright JJ, Urba W, Whang-Peng J, Kirsch IR, Raffeld M et al: Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region. Blood 70(6): 1816-23, 1987.
18. Lewin N, Aman P, Akerlund B, Gustavsson E, Carenfelt C, Lejdeborn L et al: Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation. Immunol Lett 26(1): 59-65, 1990.
19. Graham FL, Smiley J, Russell WC and Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36(1): 59-74, 1977.
20. Ross RA, Spengler BA and Biedler JL: Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71(4): 741-7, 1983.
21. Nagata S: Apoptosis by death factor. Cell 88(3): 355-65, 1997.
22. Laytragoon-Lewin N, Kashuba V, Mellstedt H and Klein G: Bcl-2 rearrangement detected by pulsed-field gel electrophoresis (PFGF) in B-chronic lymphocytic leukemia (CLL) cells. Int J Cancer 76(6): 909-12, 1998.
23. Riisbro R, Christensen IJ, Piironen T, Greenall M, Larsen B, Stephens RW et al: Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer. Clin Cancer Res 8(5): 1132-41, 2002.
24. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 21(3): 485-95, 2000.
25. Novoradovskaya N, Whitfield ML, Basehore LS, Novoradovsky A, Pesich R, Usary J, Karaca M, Wong WK, Aprelikova O, Fero M, Perou CM, Botstein D and Braman I: Universal reference RNA as a standard for microarray experiments. BMC Genomics 5: 20, 2004
26. Rowe M, Lear AL, Croom-Carter D, Davies AH and Rickinson AB: Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66(1): 122-31, 1992.
27. Flajnik MF: Comparative analyses of immunoglobulin genes: surprises and portents. Nat Rev Immunol 2(9): 688-98, 2002.
28. Uehara N, Chou YC, Galvez JJ, De-Candia P, Cardiff RD, Benezra R et al: Id-1 is not expressed in the luminal epithelial cells of mammary glands. Breast Cancer Res 5(2): R25-9, 2003.
29. Tilli CM, Ramaekers FC, Broers JL, Hutchison CJ and Neumann HA: Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Br J Dermatol 148(1): 102-9, 2003.
30. Ibrahim el C, Allory Y, Commo F, Gattegno B, Callard P and Paul P: Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-g molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma. Am J Pathol 162(2): 501-8, 2003.
31. Keresztury L, Rajczy K, Tauszik T, Gyodi E, Petranyi GG and Falus A: DNA typing revealing high HLA-Cw polymorphism completes availability of major histocompatibility complex loci in forensic medicine. Am J Forensic Med Pathol 24(1): 70-5, 2003.
32. Gatti RA, Tward A and Concannon P: Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab 68(4): 419-23, 1999.